TTPH earnings call for the period ending June 30, 2019.
News & Analysis: Tetraphase Pharmaceuticals
TTPH earnings call for the period ending March 31, 2019.
TTPH earnings call for the period ending December 31, 2018.
A key clinical trial failure sent investors fleeing for the exits.
Good news this year could make these small biotech stocks bigger.
The company announced a stock offering that will bolster its balance sheet but also dilute current investors.
The company announced positive top-line results from a phase 3 trial, which means regulatory submissions are on the way.
A glowing earnings report earlier this week continues to attract investors' attention.
This is what happens when things don't go to according to plan.
A mixed earnings report combined with a small dash of hope have investors feeling bullish on this beaten-down stock.